M. Kathleen Behrens, Director at Sarepta Therapeutics, Inc. (SRPT), bought 17,500 shares at $14.91 ($258K) on 2012-09-07, disclosed to the SEC on 2012-09-11.
Open-market purchase of $258k SRPT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.58 | 9,700 | $141K | 54.9% |
| 2 | $14.91 | 7,800 | $116K | 45.1% |
| Total | $14.73 avg | 17,500 | $258K | 100% |
| Filing → |
| IGMS | BUY | 2022-04-04 | $1.4M | — | Filing → |
| SRPT | SELL | 2021-03-10 | $429K | — | Filing → |
| IGMS | BUY | 2020-12-15 | $3.0M | — | Filing → |